Landefeld and Goldman developed a risk score that could predict the risk of a major bleeding episode in outpatients treated with warfarin. The score uses information available when the oral anticoagulant therapy is begun. The authors are from Case Western Reserve University in Cleveland and Harvard Medical School in Boston.